Tag: drug companies

November 25, 2018

What is In-licensing?

In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy?
February 8, 2018

How Are Pharma Stocks Affected by Opioid Lawsuits?

Since the news about the lawsuits starting in 2016, Insys share price has dropped 65.56 percent from $28.63 to $9.62,...
December 25, 2017

Pharmaceutical Outlook 2018: M&A Deals Could Increase Drug Development

The Investing News Network takes a look at what could be the landscape for the pharma industry and its investors...
April 3, 2017

Mylan Expands its EpiPen Recall

More than 81,000 Mylan EpiPen devices have been recalled by the company resulting from a failure to activate auto-injection.
March 7, 2017

Trump Tweets, Pharma Stocks Tumble

President Donald Trump's tweet send pharma stocks down after promising he would bring drug prices down.
March 2, 2017

The Potential of Transdermal Drug Delivery

Drugs with low oral bioavailability risk failure in clinical trial: minimal absorption, after all, can translate to reduced efficacy. As...
January 16, 2017

3 Blockbuster Drugs that Changed the Market

These three blockbuster drugs transformed pharmaceutical investing. But will we ever see anything like them again?